Alain Hovnanian
Prof Alain Hovnanian is an expert in Dermatology at Hôpital Necker-Enfants Malades (France). As of October 2026, ScienceLeadR ranks Alain Hovnanian in the top 1% of experts worldwide for Ichthyosis, Keratosis and Skin Abnormalities. Alain Hovnanian has authored 371 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 1,745 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Genetics - Immunology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1989 - 2026
Number : 371
Citations
Main journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| An Investigational Mechanism-Informed Therapy for Netherton Syndrome: Introduction to QRX003 and A Pediatric Compassionate-Use Case Report. PMID 42870205 — netherton syndrome, skin, serine proteases, kallikreins, serine proteinase inhibitors, signs and symptoms, pruritus, peptide hydrolases, protease inhibitors, therapeutics, serine | Dermatol Ther (Heidelb) | 2026 | 0 |
| ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype. PMID 42424135 — genes, rna editing, psoriasis, rna | J Exp Med | 2026 | 2 |
| Is hidradenitis suppurativa more an autoinfection than pure autoinflammation? PMID 42519325 — hidradenitis suppurativa, microbiology, hidradenitis, immune system diseases | Front Immunol | 2026 | 1 |
| Cutaneous T-cell lymphoma in the setting of NIPAL4-related nonsyndromic epidermal differentiation disorder: three cases. PMID 42482319 — cells, syphilis, lymphoma, lymphoma, t-cell, cutaneous, t-lymphocytes, dermatology, lymphoma, t-cell | Br J Dermatol | 2026 | 0 |
| History and future of RNA medicines. PMID 42417685 — genes, pharmaceutical preparations, therapeutics, history, dermatology, rna | J Invest Dermatol | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| First in human Phase 1a 1b Study of KM 023 in healthy volunteers and Olmsted syndrome patients 2025-521446-20-00 — healthy volunteers | Phase 1 | Recruiting | 2025 |
LeadR Networks
Main global connection map